(-0.72%) 5 070.75 points
(-0.58%) 38 456 points
(-1.06%) 17 477 points
(0.12%) $82.91
(0.73%) $1.665
(0.13%) $2 341.50
(0.47%) $27.48
(-0.26%) $913.40
(-0.18%) $0.933
(-0.36%) $10.94
(-0.38%) $0.799
(-0.29%) $92.06
Live Chart Being Loaded With Signals
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits...
Stats | |
---|---|
Today's Volume | 13 201.00 |
Average Volume | 282 799 |
Market Cap | 17.14M |
EPS | £0 ( 2023-09-26 ) |
Next earnings date | ( £0 ) 2024-06-25 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -1.170 |
ATR14 | £0 (0.00%) |
OptiBiotix Health PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OptiBiotix Health PLC Financials
Annual | 2022 |
Revenue: | £457 000 |
Gross Profit: | £244 000 (53.39 %) |
EPS: | £0.0293 |
Q2 | 2023 |
Revenue: | £351 000 |
Gross Profit: | £65 000.00 (18.52 %) |
EPS: | £-0.0209 |
Q4 | 2022 |
Revenue: | £338 102 |
Gross Profit: | £75 219.00 (22.25 %) |
EPS: | £-0.120 |
Q2 | 2022 |
Revenue: | £118 898 |
Gross Profit: | £-55 219.00 (-46.44 %) |
EPS: | £0.160 |
Financial Reports:
No articles found.
OptiBiotix Health PLC
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators